Back to Journals » Drug Design, Development and Therapy » Volume 15

No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects

Total article views   Abstract views HTML views PDF downloads Totals
427 Dovepress* 427 0+ 31 427
Totals 427 0 31 427
*Since 28 April 2021
+Since July 2016

View citations on Google Scholar